Epoetin zeta
Therapeutic Epoetin Zeta antibody from the biosimilar Silapo® commercial drug.
Reference Standard as Aliquots
Biosimilars as Aliquots
Product Batch | Therapeutic Expiry Date
| Brand & Origin
| Amount per Aliquot
| Select Quantity | Discount | Price per Aliquot
| |
|---|---|---|---|---|---|---|---|
2022.08 |
Silapo® DE |
5000 IU |
Unit: aliquot(s) |
385,00 €
/aliquot
|
Access Batch Specific Analytical Information
Evidentic’s Analytical Data Service includes a comprehensive array of methods to support the drug development process, including structure, aggregation, degree of isomerization, and N-glycans identification of the active pharmaceutical ingredient (API).
Product Information
Here you will find the product information for the reference product.
Silapo® / Epoetin zeta Biosimilar Drug
| Drug name | Silapo® |
| INN | Epoetin zeta |
| API type | Glycoprotein hormone |
| Pharmacotherapeutic group | Other antianaemic preparations, erythropoietin |
| ATC code | B03XA01 |
| Target of antibody | Erythropoietin cell surface receptors |
| General function | Epoetin zeta is indicated for the treatment of symptomatic anaemia associated with chronic renal failure (CRF) |
| Short description | |
| Pharmacodynamic properties (Mechanism of action; Source EMA document) | Epoetin zeta is a biosimilar medicinal product. Erythropoietin (EPO) is a glycoprotein hormone produced primarily by the kidney in response to hypoxia and is the key regulator of RBC production. EPO is involved in all phases of erythroid development, and has its principal effect at the level of erythroid precursors. After EPO binds to its cell surface receptor, it activates signal transduction pathways that interfere with apoptosis and stimulates erythroid cell proliferation. Recombinant human EPO (epoetin zeta), expressed in Chinese hamster ovary cells, has a 165 amino acid sequence identical to that of human urinary EPO; the 2 are indistinguishable on the basis of functional assays. The apparent molecular weight of erythropoietin is 32 000 to 40 000 dalton |
| Pharmacodynamic properties (Pharmacodynamic effects; Source EMA document) | After single doses (20 000 to 160 000 IU subcutaneously) of epoetin alfa, a dose-dependent response was observed for the pharmacodynamic markers investigated including: reticulocytes, RBCs, and haemoglobin. |
| Original license holder | Stada Arzneimittel AG |
| Marketing authorisation numbers | EU/1/07/432/001- EU/1/07/432/047 |
| Marketing authorisation holder | STADA Arzneimittel AG Stadastrasse 2-18 D-61118 Bad Vilbel Germany |
| Name of the manufacturer of the biological active substance | Norbitec GmbH Pinnauallee 4 D-25436 Uetersen Germany |
| Name and address of the manufacturer(s) responsible for batch release | STADA Arzneimittel AG Stadastrasse 2-18 D-61118 Bad Vilbel Germany |
| Max shelf life | 30 months |
| Storage conditions | 2°C – 8°C |
| List of excipients | Disodium phosphate dihydrate, Sodium dihydrogen phosphate dihydrate, Sodium chloride, Calcium chloride dihydrate, Polysorbate 20, Glycine, Leucine, Isoleucine ,Threonine, Glutamic acid, Phenylalanine, Sodium hydroxide (pH adjuster), Hydrochloric acid (pH adjuster). Contains phenylalanine. |
Support
Do you have a question about the product? Reach out to our team using the form below – we’d be happy to help you!
Ready to simplify your sourcing?
Here’s how to get started:
Select Your Licensed Molecules
Browse our shop and choose the licensed molecule(s) you need. Don’t worry if you can’t find the molecule you’re looking for – we can source it for you!
Get a Quote
Receive a confidential, non-binding quote for the molecule(s) you choose.
Get Qualified & We Deliver
Complete our quick qualification process, place your order, and we’ll ship your molecule(s) within days.
Do you have a question you'd like to ask us?
Here’s how to get started:
